Radiomics assessment can also be repeatedly performed throughout the duration of treatment, without requiring additional invasive testing procedures to obtain tumor tissue from surgery or biopsy, thereby reflecting dynamic PD-L1 expression for treatment stratification and for monitoring the therapeutic efficacy of checkpoint inhibitors to potentially instruct drug replacement and discontinuation. Here, CD274 is linked to neoplasm.